Health · Bagsværd, Denmark Novo's CagriSema shows 25% weight loss in women in late-stage analysis Novo Nordisk released a late-stage analysis showing its experimental CagriSema injection produced 25% weight loss in women. The company said it could improve on results from its existing obesity drug Wegovy. CNBC · See it on the globe